Trial Profile
A phase I, double-blind, randomized, placebo-controlled, sequential multiple ascending dose study of RG-7410 in healthy volunteers
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 11 Dec 2014
Price :
$35
*
At a glance
- Drugs RG 7410 (Primary)
- Indications Schizophrenia
- Focus Adverse reactions
- 11 Dec 2014 New trial record